PYXS Pyxis Oncology, Inc.

2d ago, source: Seeking Alpha

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat cancers. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

Does Pyxis Oncology (PYXS) Have the Potential to Rally 61.29% as Wall Street Analysts Expect?

13d ago, source: Hosted on MSN

Pyxis Oncology, Inc. (PYXS) closed the last trading session at $5.27, gaining 11.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights

29d ago, source: Business Insider

As part of Pyxis Oncology's acquisition of Apexigen, Inc., in August 2023, the Company gained rights to royalties on Beovu and another asset discovered using APXiMAB, Apexigen's proprietary ...

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28d ago, source: Nasdaq

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers ...

Pyxis Oncology, Inc. (PYXS)

29d ago, source: Yahoo Finance

Sullivan, M.D BOSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to ...

Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights

1mon ago, source: Stockhouse

As part of Pyxis Oncology's acquisition of Apexigen, Inc., in August 2023, the Company gained rights to royalties on Beovu and another asset discovered using APXiMAB, Apexigen's proprietary antibody ...

Pyxis Oncology, Inc. (PYXS)

6d ago, source: Yahoo Finance

Sullivan, M.D BOSTON, March 07, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to ...

Pyxis Oncology Inc PYXS

10d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Pyxis Oncology Inc.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...